Metallomics in pulmonary arterial hypertension patients.

"CONFLICT OF INTEREST STATEMENT EKK provided consultative services to Acceleron, Merck, United Therapeutics served on advisory boards for J&J, Actelion, and United Therapeutics, received institutional research funding from J&J Actelion and United Therapeutics, and participated in a United Therapeutics speaker's bureau (2018–2021)."

"The authors were supported in part by the University of Louisville Executive Vice President for Research and Innovation Internal Grant (JH, LC); University of Louisville School of Medicine Basic Grant (JH, LC); National Institute of Environmental Health Sciences (P30ES030283 to JH, LC, MCC); Gilead Sciences COMMIT COVID‐19 RFP Program grant (Gilead IN‐US‐983‐6063 to JH); National Center for Advancing Translational Sciences grant (1U18TR003787‐01 to JH); National Institute Heart and Lung (R01HL125877, R01HL160927 to LC). National Heart, Lung and Blood Institute (1R01HL15877‐01 to JH). YMG is supported by National Institute of Health R01 ES031980 and R21 ES031814. RS is supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. National Institute of Environmental Health Sciences (R35ES028373, R01ES032189, P42ES023716, and R21ES031510 to MCC). National Institute of General Medical Sciences (P20GM113226 to MCC). National Institute of Health (NIDDK RC2 DK118619 and NIEHS P30 ES019776 to DPJ)."